IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
about
Helminth infections: the great neglected tropical diseasesIL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infectionGoblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation.Characterisation of effector mechanisms at the host:parasite interface during the immune response to tissue-dwelling intestinal nematode parasites.Structures and biological functions of IL-31 and IL-31 receptors.Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier FunctionIncreased levels of interleukin 31 (IL-31) in osteoporosis.Using eggs from Schistosoma mansoni as an in vivo model of helminth-induced lung inflammationMechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitisThe release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms.New drugs targeting Th2 lymphocytes in asthma.Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusionInterleukin-31 expression and relation to disease severity in human asthma.Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.The enigmatic cytokine oncostatin m and roles in diseasePretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation.Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science.Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.Regulation of Th2 responses by different cell types expressing the interleukin-31 receptorAnalysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.A review on interleukins: The key manipulators in rheumatoid arthritis.Transcriptional activation of the IL31 gene by NFAT and STAT6.Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.David Artis: Fear no worm. Interview by Amy Maxmen.Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo.IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity.Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.Effect of interleukin-31 on septic shock through regulating inflammasomes and interleukin-1β.IL-33/IL-31 Axis: A Potential Inflammatory Pathway.
P2860
Q24648324-FA2E287D-C603-49F7-8B99-6039964A3224Q28512078-135F21C9-B1E2-4E00-A597-7C032BA7C965Q33642117-F373C721-A8D5-4007-82E0-18081431F734Q33743673-C15845EE-09C4-4BC9-A6AF-2203ADE03AB1Q34858355-A99AD4F4-4B82-4A52-A88E-E4BB3FB5C142Q35954120-78FECB51-8A4F-4968-83A2-20C0D4DFEE8FQ36111385-DBA79B56-3C12-4798-963A-E331083D5CD9Q36142219-4EB656E9-337C-4C3A-80CF-9B939F170FBCQ36317429-9B01795C-139E-4B6A-AF00-1B3DF01505FEQ36351112-D64D6988-A861-4E17-A35F-18F3B527102EQ36430741-BF319B3B-4D8F-475F-AAAD-DA78310E0D25Q36485165-E93478D5-E51B-480A-AB03-2291294BBB9CQ36562854-28EFCE6E-B8F8-45F4-8963-C7A70E63CB0DQ36569880-7081FDA3-FCE7-4B48-9E1E-60EFC28E604BQ36666764-25AB696D-18BD-45D8-ADB6-7BF330D612EEQ37071840-35AEE117-E7CC-4C44-8713-3BB6848F11ECQ37273324-1F2FCCDF-1E43-4B0C-B8D9-00F726DE3B15Q37409222-C1175A94-219D-486F-B6F3-9E7AE4B491F2Q37465452-47323F0B-B769-4ED2-8AAB-414155973950Q37832061-BEF46028-C087-4A13-9E2C-3ED1ECB2C566Q38625077-9754104C-3DC5-4C84-B09F-244D82B73068Q38827598-E39E3EE5-D513-4FBC-944B-FFD7ADF5C954Q38930782-D362EFAB-FC1F-4BE1-931E-074AEDA00241Q39029629-B0DC95D4-82FC-44DA-9B1E-4CCE8801B084Q39339002-57B1AFB5-5FD2-4E80-8CDB-32354AD41021Q39410617-B8103828-3825-4365-A203-D1B555D0938CQ42012743-37510053-09BF-4414-AF2F-8DA4082219B3Q43176440-1E6A1595-0B06-4B50-8E4C-4BBCD4A97C9DQ47992175-D209DA85-33EC-4D04-82AE-9459A04F2385Q48178703-B0660AA5-E691-4C6C-AE41-C1714641CA64Q52716093-B39BC953-63FC-4421-98BC-170E3BC018F5Q54209518-96E827B9-EA24-43C3-9C82-92E3B10C140EQ55296740-94CAB4AC-41D6-40B5-BDAD-98AF3B23A2B9Q55365826-12EF6D8D-754B-4613-BAD2-FCAD180E7E26
P2860
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@ast
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@en
type
label
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@ast
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@en
prefLabel
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@ast
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@en
P2093
P2860
P50
P356
P1476
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
@en
P2093
David Artis
Edward J Pearce
Frederic J de Sauvage
Jacqueline G Perrigoue
Phillip Scott
P2860
P304
P356
10.1084/JEM.20061791
P407
P577
2007-03-12T00:00:00Z